Skip to content

Non-Dispensing Evaluation of an Investigational Galyfilcon A Soft Contact Lens

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01054807
Enrollment
32
Registered
2010-01-22
Start date
2009-11-01
Completion date
2010-03-01
Last updated
2018-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The purpose of this investigation is to compare the fit characteristics and vision attributes of an investigational Galyfilcon A contact lens and an approved Galyfilcon A contact lens.

Interventions

DEVICEGalyfilcon A Habitual Lens

Comparison of three soft contact lens designs.

DEVICEGalyfilcon A 8.7 BC (Investigational)

Comparison of three soft contact lens designs.

DEVICEGalyfilcon A 8.3 BC (Investigational)

Comparison of three soft contact lens designs

Sponsors

Coles-Brennan Pty Ltd
CollaboratorUNKNOWN
Johnson & Johnson Vision Care, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be of legal age (i.e., at least 18 years old) * Sign a written informed consent * Have contact lens distance sphere requirement in the range -1.00D to -6.00D * Have spectacle astigmatism \<1.25D in each eye * Currently wear ACUVUE® ADVANCE™ (for at least 6 months) with documentation of current prescription. * Have normal eyes with no evidence of abnormality or disease.

Exclusion criteria

* Required concurrent ocular medication * Any systemic illness which would contra-indicate lens wear or the medical treatment of which would affect vision or successful lens wear. * Eye injury or surgery within eight weeks immediately prior to enrollment for this study. * Abnormal lacrimal secretions * Pre-existing ocular irritation that would preclude contact lens fitting. * Keratoconus or other corneal irregularity. * Pregnancy, lactating or planning a pregnancy at the time of enrolment. * Participation in any concurrent clinical trial * Known allergy to silver, silver ions, or silver containing compounds.

Design outcomes

Primary

MeasureTime frameDescription
Comparison of Lens Fit CharacteristicsApproximately 40 minutes of wear timeAt the screening visit, the following baseline measurements will be taken of the subject's habitual contact lenses (Control): * Visual Acuity (logMar) * Over-refraction with Visual Acuity * Fit acceptability (acceptable/non-acceptable)
Evaluation of Inter-ChangeabilityApproximately 40 minutes of wear timeIn a bilateral fashion, the subject will wear Test/Control lens according to a pre-designed randomization schedule. Immediately upon insertion, the following variables will be assessed: * Ease of handling of the lenses- by Investigator * Comfort on insertion After 30-40 minutes of settling time the following variables will be collected: * Subjective comfort after settling * Visual Acuity (logMar) * Corneal coverage (Y/N) * Post-blink movement (mm) * Version Lag (mm) * Tightness on push-up (0-100 scale) * Overall fit acceptance (0-5 scale)
Determination of fit or Vision DifferencesApproximately 40 minutes of wear timeIn a bilateral fashion, the subject will wear Test/Control lens according to a pre-designed randomization schedule. Immediately upon insertion, the following variables will be assessed: * Ease of handling of the lenses- by Investigator * Comfort on insertion After 30-40 minutes of settling time the following variables will be collected: * Subjective comfort after settling * Visual Acuity (logMar) * Corneal coverage (Y/N) * Post-blink movement (mm) * Version Lag (mm) * Tightness on push-up (0-100 scale) * Overall fit acceptance (0-5 scale)

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026